flavin-mononucleotide and Brain-Damage--Chronic

flavin-mononucleotide has been researched along with Brain-Damage--Chronic* in 1 studies

Trials

1 trial(s) available for flavin-mononucleotide and Brain-Damage--Chronic

Article	Year
[Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:8 We examined 60 patients with constitutional venous insufficiency, suffering from hypertensive encephalopathy of I and II stages, mean age 43,4± 6,3 years. Patients of the main group (n=30) received Cytoflavin (2 tablets twice a day) and standard therapy (acetylsalicylic acid and antihypertensive drugs). Thirty patients of the parallel group received only standard therapy. At the 25th day of the study, there were the decrease in the number of complaints, including specific "venous complaints", the reduction of cephalalgia syndrome, asthenic and autonomic disorders; the improvement of quality of life and better cerebral hemodynamics on all structural and functional levels. Topics: Adult; Brain Damage, Chronic; Drug Administration Schedule; Drug Combinations; Female; Flavin Mononucleotide; Humans; Hypertension; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Quality of Life; Succinates; Treatment Outcome; Venous Insufficiency	2012

Article

Year

[Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:8

We examined 60 patients with constitutional venous insufficiency, suffering from hypertensive encephalopathy of I and II stages, mean age 43,4± 6,3 years. Patients of the main group (n=30) received Cytoflavin (2 tablets twice a day) and standard therapy (acetylsalicylic acid and antihypertensive drugs). Thirty patients of the parallel group received only standard therapy. At the 25th day of the study, there were the decrease in the number of complaints, including specific "venous complaints", the reduction of cephalalgia syndrome, asthenic and autonomic disorders; the improvement of quality of life and better cerebral hemodynamics on all structural and functional levels.

Topics: Adult; Brain Damage, Chronic; Drug Administration Schedule; Drug Combinations; Female; Flavin Mononucleotide; Humans; Hypertension; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Quality of Life; Succinates; Treatment Outcome; Venous Insufficiency

2012